Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data

Abdulrhim, Sara; Awaisu, Ahmed; Ibrahim, Mohamed Izham Mohamed; Diab, Mohammad; Hussain, Mohamed Abdelazim Mohamed; Raey, Hend Al; Ismail, Mohammed Thahir; Sankaralingam, Sowndramalingam

doi:10.1007/s11096-021-01327-x

Cited by 6 publications

(2 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cuando la atención sanitaria de los pacientes diabéticos recae principalmente sobre los profesionales médicos, pueden obtenerse resultados subóptimos. El seguimiento de los pacientes por un equipo multidisciplinar facilita la consecución de los objetivos terapéuticos 8 . Un ensayo clínico aleatorizado concluyó que la adición de atención farmacéutica en pacientes con DM2 conduce a un mejor control de los valores de HbA1c 9 .…”

Section: Introductionunclassified

Impacto de una unidad de farmacia de atención primaria en la optimización del tratamiento farmacológico de pacientes diabéticos tipo 2

Canadell-Vilarrasa,

Palanques-Pastor,

Campabadal-Prats

et al. 2024

Atención Primaria

View full text Add to dashboard Cite

Section: Introductionunclassified

Impacto de una unidad de farmacia de atención primaria en la optimización del tratamiento farmacológico de pacientes diabéticos tipo 2

Canadell-Vilarrasa,

Palanques-Pastor,

Campabadal-Prats

et al. 2024

Atención Primaria

View full text Add to dashboard Cite

“…The Middle East may differ from the Western countries in terms of the clinical settings and the local clinical practice guidelines. Moreover, there is a diversity in the nationalities of healthcare providers in the Middle East, and particularly in the Gulf region, where clinicians come from different medical backgrounds with various experiences [ 48 ]. These differences could contribute to different prescribing patterns.…”

Section: Introductionmentioning

confidence: 99%

A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabetic drugs. To date, there are no pharmacoepidemiologic studies investigating the pattern of use of SGLT2is compared to other oral antidiabetic drugs in the Middle East, including Qatar. Aim This study aimed to explore the trends in the use of SGLT2is compared to other oral antidiabetic drugs in Qatar from 2016 to 2020. Method This is a descriptive, retrospective cross-sectional study where information on all oral antidiabetic drugs dispensed as in- or out-patient prescriptions from 2016 to 2020 in Hamad Medical Corporation hospitals, Qatar were collected. Outcomes included the number and relative frequency of quarterly prescriptions of different oral antidiabetic drug classes [biguanides, sulfonylureas, dipeptidyl peptidase 4 inhibitors, thiazolidinediones, meglitinides, α-glucosidase inhibitors, and SGLT2is] prescribed from 2016 to 2020. Results SGLT2is prescriptions increased from 1045 (2.13%) in 2017 to 8375 (12.39%) in 2020, while sulfonylureas prescriptions declined from 10,436 (21.25%) to 9158 (13.55%) during the same period. Metformin use decreased from 23,926 (48.71%) in 2017 to 30,886 (45.70%) in 2020. The proportions of thiazolidinediones, meglitinides, α-glucosidase inhibitors prescriptions remained stable over the years. Among SGLT2is, empagliflozin prescriptions showed an increase from 537 (10.65%) to 2881 (34.40%) compared to dapagliflozin, which decreased by the end of 2018 from 4505 (89.35%) to 5494 (65.6%). Conclusion SGLT2is have largely replaced sulfonylureas in Qatar. The increasing trend in their use over the years is similar to that reported in other countries. The trend among SGLT2is suggests greater preference for empagliflozin over dapagliflozin.

show abstract

Evidence on Real-World Data and Real-World Evidence As a Driver for Precision Medicine Implementation in Pharmacy Practice

Hendricks‐Sturrup

Francis

2023

Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy

View full text Add to dashboard Cite

Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data

Cited by 6 publications

References 47 publications

Impacto de una unidad de farmacia de atención primaria en la optimización del tratamiento farmacológico de pacientes diabéticos tipo 2

Impacto de una unidad de farmacia de atención primaria en la optimización del tratamiento farmacológico de pacientes diabéticos tipo 2

A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country

Evidence on Real-World Data and Real-World Evidence As a Driver for Precision Medicine Implementation in Pharmacy Practice

Contact Info

Product

Resources

About